Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of VECOPA regimen optimization in Hodgkin disease
2004-005244-28Phase 4Completed
- Sponsor
- Leipzig University
- Start
- Feb 2005
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxorubicin, etoposide, vincristine, vinblastine, cyclophosphamide in Hodgkin lymphoma (HL), sponsored by Leipzig University. Started Feb 2005; status: completed.
02
Drugs
doxorubicinetoposidevincristinevinblastinecyclophosphamide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on 2004-005244-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005244-28.